Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer (Q38161514)

30 August 2017

title

Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer (English)

1 reference

30 August 2017

0 references

1 reference

Ashutosh K Tewari

1 reference

30 August 2017

Daniel P Nguyen

1 reference

30 August 2017

Jinyi Li

series ordinal

1 reference

30 August 2017

Shalini S Yadav

series ordinal

1 reference

30 August 2017

publication date

20 February 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

114

1 reference

30 August 2017

1 reference

30 August 2017

page(s)

168-176

1 reference

Hallmarks of Cancer: The Next Generation

30 August 2017

cites work

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior

21 January 2018

1 reference

Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells

21 January 2018

1 reference

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

The noncanonical NF-κB pathway

21 January 2018

1 reference

21 January 2018

1 reference

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression

21 January 2018

1 reference

NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression

21 January 2018

1 reference

Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages

21 January 2018

1 reference

Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes

21 January 2018

1 reference

RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity

21 January 2018

1 reference

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines

21 January 2018

1 reference

ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner

21 January 2018

1 reference

Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.

21 January 2018

1 reference

Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer

21 January 2018

1 reference

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

21 January 2018

1 reference

Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation

21 January 2018

1 reference

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

21 January 2018

1 reference

ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression

21 January 2018

1 reference

Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction

21 January 2018

1 reference

NF??B: A Pivotal Transcription Factor in Prostate Cancer Metastasis to Bone

21 January 2018

1 reference

Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone

21 January 2018

1 reference

PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells

21 January 2018

1 reference

Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

21 January 2018

1 reference

Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha

21 January 2018

1 reference

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells

21 January 2018

1 reference

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

21 January 2018

1 reference

NF-kappaB regulates androgen receptor expression and prostate cancer growth

21 January 2018

1 reference

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells

21 January 2018

1 reference

NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation

21 January 2018

1 reference

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells

21 January 2018

1 reference

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

21 January 2018

1 reference

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence

21 January 2018

1 reference

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma

21 January 2018

1 reference

A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer

21 January 2018

1 reference

Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy

21 January 2018

1 reference

Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer

21 January 2018

1 reference

IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines.

21 January 2018

1 reference

Nuclear Factor- B Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

21 January 2018

1 reference

Expression of NF-?B in prostate cancer lymph node metastases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJU.12488

1 reference

30 August 2017

1 reference